People: West Pharmaceutical Services Inc (WST)

WST on New York Consolidated

44.79USD
19 Sep 2014
Price Change (% chg)

$-0.10 (-0.22%)
Prev Close
$44.89
Open
$44.94
Day's High
$45.05
Day's Low
$44.36
Volume
675,271
Avg. Vol
301,398
52-wk High
$51.12
52-wk Low
$39.11

Search Stocks

Summary

Name Age Since Current Position

Donald Morel

56 2006 Chairman of the Board, Chief Executive Officer

William Federici

54 2013 Chief Financial Officer, Senior Vice President

Warwick Bedwell

54 2011 President - Pharmaceutical Packaging Systems Asia Pacific Region

Karen Flynn

51 2012 President - Pharmaceutical Packaging Systems Americas Region

Heino Lennartz

48 2010 President - Pharmaceutical Packaging Systems Europe Region

John Paproski

57 2009 President - Pharmaceutical Delivery Systems

John Gailey

59 2013 Senior Vice President, General Counsel

Richard Luzzi

62 2013 Senior Vice President - Human Resources

Daniel Malone

52 2011 Vice President, Corporate Controller

Michael Anderson

58 2001 Vice President, Treasurer

Rachael Bushey

36 2013 Vice President, Deputy General Counsel and Corporate Secretary

Mark Buthman

53 2011 Independent Director

William Feehery

43 2012 Independent Director

Thomas Hofmann

62 2007 Independent Director

Paula Johnson

54 2005 Independent Director

Myla Lai-Goldman

56 2014 Independent Director

Douglas Michels

57 2011 Independent Director

John Weiland

58 2007 Independent Director

Anthony Welters

59 1997 Independent Director

Patrick Zenner

67 2002 Independent Director

Biographies

Name Description

Donald Morel

Dr. Donald E. Morel, Jr., Ph.D. is Chairman of the Board, Chief Executive Officer of West Pharmaceutical Services, Inc. Dr. Morel has been our Chief Executive Officer since April 2002 and Chairman of the Board since March 2003. Dr. Morel was our President from April 2002 to June 2005. He serves as a director of Fox Chase Cancer Center and as a member of the board of trustees of The Franklin Institute and of Lafayette College.

William Federici

Mr. William J. Federici is Chief Financial Officer, Senior Vice Presidentof West Pharmaceutical Services, Inc., since joining the Company in August 2003. He was National Industry Director for Pharmaceuticals of KPMG LLP (accounting firm) from June 2002 until August 2003 and prior thereto, an audit partner with Arthur Andersen, LLP.

Warwick Bedwell

Mr. Warwick Bedwell is President - Pharmaceutical Packaging Systems Asia Pacific Region of West Pharmaceutical Services, Inc., since January 3, 2011. Previously, he served as Vice President and Commercial Director-Bone and Rheumatology for Roche Products (UK) Limited, a biotech company, from October 2008 to August 2010. From January 2007 to October 2008, he served as Vice President and Global Head of Business Development for Hoffman LaRoche Inc. (U.S.) and from June 2003 to December 2006, he served as President and General Manager of Roche Inc. in the Philippines. Prior thereto, he held numerous positions in commercial operations for Roche Products Pty Ltd. in Australia.

Karen Flynn

Ms. Karen A. Flynn is President - Pharmaceutical Packaging Systems Americas Region of West Pharmaceutical Services, Inc., since June 2012. She was Vice President, Sales from May 2008 to June 2012. From 2000 to 2008, she worked in Sales Management, most recently as Vice President, Global Accounts, for Catalent (formerly known as Cardinal Health). Prior thereto, she held various positions at West, including Quality, Research and Development, and Sales.

Heino Lennartz

Mr. Heino Lennartz is President - Pharmaceutical Packaging Systems Europe Region of West Pharmaceutical Services, Inc., since February 2010. Prior thereto, he served as President, Europe, Pharmaceutical Systems since July 2009. He was Vice President Finance, MIS & Purchasing for Europe & Asia Pacific from December 2006 until July 2009. Mr. Lennartz was Vice President Corporate Finance of AIXTRON AG, from 2003 to 2006 and, prior thereto, held various positions, including Director Business Systems Europe, at GDX Automotive, a rubber and plastic car body sealing system supplier.

John Paproski

Mr. John E. Paproski is President - Pharmaceutical Delivery Systems of West Pharmaceutical Services, Inc., since December 2009. He was Vice President of Innovation, from January 2005 to December 2009 and Vice President, Global Product Development from August 1996 to January 2005. He has held numerous other operations and engineering positions within the Company, including Vice President of Rubber Operations from August 1993 to January 2005 and Director of Manufacturing Engineering from 1991 to 1993.

John Gailey

Mr. John R. Gailey, III., is Senior Vice President, General Counsel of West Pharmaceutical Services, Inc. He is Vice President since December 1995, General Counsel since May 1994 and Secretary since December 1991. He served as Corporate Counsel from 1991 until his appointment as General Counsel.

Richard Luzzi

Mr. Richard D. Luzzi is Senior Vice President - Human Resources of West Pharmaceutical Services, Inc., since June 2002. He served as Vice President, Human Resources of GS Industries, a steel manufacturer, from 1998 to 2002, Vice President, Human Resources of Lukens Steel from 1993 to 1998, and Vice President, Human Resources of Rockwell International, from 1990 to 1993.

Daniel Malone

Mr. Daniel Malone is Vice President, Corporate Controller of West Pharmaceutical Services, Inc., since August 1, 2011. He was Vice President of Finance, Pharmaceutical Packaging Systems Americas Region from September 2008 to August 2011 and Director of Financial and Management Reporting from October 1999 to September 2008.

Michael Anderson

Mr. Michael A. Anderson is Vice President, Treasurer of West Pharmaceutical Services, Inc., since June 2001. He was Finance Director, Drug Delivery Systems Division from October 1999 to June 2001, Vice President, Business Development from April 1997 to October 1999 and Director of Taxes from July 1992 to April 1997.

Rachael Bushey

Ms. Rachael M. Bushey is Vice President, Deputy General Counsel and Corporate Secretary of West Pharmaceutical Services, Inc., since October 2013. Previously, she served as Assistant General Counsel and Assistant Secretary from May 2012 until October 2013, and Associate Counsel, Securities and Corporate Governance Matters, from December 2010 until May 2012. Prior to joining West, she was a corporate attorney at the law firm of Pepper Hamilton LLP.

Mark Buthman

Mr. Mark A. Buthman is an Independent Director of West Pharmaceutical Services, Inc., since February 22, 2011. Mr. Buthman has been Senior Vice President and Chief Financial Officer of Kimberly-Clark Corporation since 2003. He joined Kimberly-Clark in 1982. Mr. Buthman was appointed Vice President of Strategic Planning and Analysis in 1997 and Vice President of Finance in 2002. Mr. Buthman is a member of the Board of Directors of Pavillon, International and K-C de Mexico S.A., C.V.

William Feehery

Dr. William F. Feehery, Ph.D. is an Independent Director of West Pharmaceutical Services, Inc., since February 21, 2012. Dr. Feehery has been President of Industrial Biosciences at E. I. du Pont de Nemours and Company since November 2013. He served as Global Business Director, DuPont Photovoltaic Solutions and previously as Global Business Director, Electronics Growth Businesses and as President of DuPont Displays, Inc. He joined DuPont in 2002. Prior to joining DuPont he was engaged in venture capital and was a management consultant for the Boston Consulting Group.

Thomas Hofmann

Mr. Thomas W. Hofmann is an Independent Director of West Pharmaceutical Services, Inc., since October 2007. Mr. Hofmann is the retired Senior Vice President and CFO of Sunoco, Inc. (oil refining and marketing company), where he served in that capacity from January 2002 until December 2008. Mr. Hofmann also served Sunoco in various other senior management roles since 1990. Mr. Hofmann provides substantial financial, corporate governance and management experience with expertise in all areas of finance, including tax, accounting, auditing, treasury, investor relations and budgeting, and he is well-versed in strategic planning, risk-management and capital-market issues. During a distinguished career with Sunoco, Inc., Mr. Hofmann was involved in a number of unique transactions, including significant acquisitions and divestitures.

Paula Johnson

Dr. Paula A. Johnson, M.D. is an Independent Director of West Pharmaceutical Services, Inc., since October 2005. She is a cardiologist and has been the Executive Director of the Connors Center for Women’s Health and Gender Biology and Chief of the Division of Women’s Health at Brigham and Women’s Hospital since January 2002. Dr. Johnson is an Associate Professor at Harvard Medical School.

Myla Lai-Goldman

Dr. Myla P. Lai-Goldman, M.D., is an Independent Director of West Pharmaceutical Services, Inc. Dr. Lai-Goldman is Chief Executive Officer and President of GeneCentric Diagnostics, Inc., (molecular diagnostics company) since June 2011. She also serves as the managing partner of Personalized Science, LLC, a clinical diagnostics consulting company she founded in 2008. Since August 2011, Dr. Lai-Goldman has been a Venture Partner at Hatteras Venture Partners. From June 2009 to December 2010, Dr. Lai-Goldman was Chief Executive Officer and Chief Scientific Officer of CancerGuide Diagnostics, Inc. (genomic-based clinical and pharmaceutical cancer testing and services). Prior to that time, Dr. Lai-Goldman served in various roles at Laboratory Corporation of America Holdings and its predecessor company, Roche Biomedical Laboratories (clinical laboratory company), including Executive Vice President, Chief Medical Officer and Chief Scientific Officer.

Douglas Michels

Mr. Douglas A. Michels is an Independent Director of West Pharmaceutical Services, Inc., since February 22, 2011. Mr. Michels serves as President and Chief Executive Officer of OraSure Technologies, Inc. and a member of the OraSure Board of Directors, positions he has held since June 2004. He also serves as a member of the board of directors of St. Luke’s University Hospital and Health Network in Bethlehem, Pennsylvania. In February 2010, Mr. Michels was appointed to the Presidential Advisory Council on HIV/AIDS. He previously served on the Board of the National Blood Foundation, the Board of the National Committee for Quality Health Care and the Coalition to Protect America’s Health Care.

John Weiland

Mr. John H. Weiland is an Independent Director of West Pharmaceutical Services, Inc., since May 2007. Mr. Weiland has been President and Chief Operating Officer of C. R. Bard, Inc., a medical-device company, since August 2003, and served as its Group President from April 1997 to August 2003 and its Group Vice President from March 1996 to April 1997. Mr. Weiland also serves as a director of C. R. Bard, Inc. In 2012, Mr. Weiland received the prestigious Horatio Alger Award and now serves as a director.

Anthony Welters

Mr. Anthony Welters is an Independent Director of West Pharmaceutical Services, Inc., since March 1997. Mr. Welters has been Executive Vice President, UnitedHealth Group Inc. (diversified health and well-being company) since December 2006. In 2011, he joined the Office of the CEO. Mr. Welters served as President of the Public and Senior Markets Group from September 2007 to December 2010. He had previously been President and Chief Executive Officer of AmeriChoice Corporation, which was acquired by UnitedHealth Group in 2002. Mr. Welters founded AmeriChoice in 1989. He serves as Vice Chair of New York University, Chairman of Morehouse School of Medicine, Chair of the New York University School of Law Board of Trustees and a trustee of the New York University School of Medicine. During 2012 Mr. Welters was appointed to the Kennedy Center for Performing Arts and inducted into the American Academy of Arts & Sciences. Mr. Welters is the recipient of the prestigious Horatio Alger Award and serves as a director.

Patrick Zenner

Mr. Patrick J. Zenner is an Independent Director of West Pharmaceutical Services, Inc., since July 2002. Mr. Zenner is retired from Hoffmann-La Roche Inc., North America, the prescription drug unit of the Roche Group, a leading research-based healthcare enterprise, where he served as President and Chief Executive Officer from 1993 to January 2001. He was a director and the Chairman of the Board of Exact Sciences Corporation until July 2010, and from July 2007 until March 2008, served as its Interim CEO. He also served as Interim Chief Executive Officer of CuraGen Corporation from May 2005 through March 2006. In addition, Mr. Zenner serves as Chairman of the Board and a director of ArQule, Inc. He previously served as director of Xoma Corporation from 2002 to 2010 and Par Pharmaceuticals from 2009 to 2012.

Options Compensation

Search Stocks